rs4532349

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_003664.5(AP3B1):​c.1038T>C​(p.Asn346Asn) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,604,018 control chromosomes in the GnomAD database, including 38,199 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2847 hom., cov: 32)
Exomes 𝑓: 0.21 ( 35352 hom. )

Consequence

AP3B1
NM_003664.5 splice_region, synonymous

Scores

2
Splicing: ADA: 0.001395
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 3.11

Publications

19 publications found
Variant links:
Genes affected
AP3B1 (HGNC:566): (adaptor related protein complex 3 subunit beta 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is part of the heterotetrameric AP-3 protein complex which interacts with the scaffolding protein clathrin. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2012]
AP3B1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 5-78177341-A-G is Benign according to our data. Variant chr5-78177341-A-G is described in ClinVar as [Benign]. Clinvar id is 178705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP3B1NM_003664.5 linkc.1038T>C p.Asn346Asn splice_region_variant, synonymous_variant Exon 9 of 27 ENST00000255194.11 NP_003655.3 O00203-1A0A0S2Z5J4
AP3B1NM_001271769.2 linkc.891T>C p.Asn297Asn splice_region_variant, synonymous_variant Exon 9 of 27 NP_001258698.1 O00203-3A0A0S2Z5J4
AP3B1NM_001410752.1 linkc.1038T>C p.Asn346Asn splice_region_variant, synonymous_variant Exon 9 of 23 NP_001397681.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP3B1ENST00000255194.11 linkc.1038T>C p.Asn346Asn splice_region_variant, synonymous_variant Exon 9 of 27 1 NM_003664.5 ENSP00000255194.7 O00203-1

Frequencies

GnomAD3 genomes
AF:
0.184
AC:
27948
AN:
152022
Hom.:
2843
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.115
Gnomad AMI
AF:
0.164
Gnomad AMR
AF:
0.270
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.0694
Gnomad SAS
AF:
0.124
Gnomad FIN
AF:
0.165
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.224
Gnomad OTH
AF:
0.185
GnomAD2 exomes
AF:
0.194
AC:
48604
AN:
251172
AF XY:
0.188
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.298
Gnomad ASJ exome
AF:
0.173
Gnomad EAS exome
AF:
0.0598
Gnomad FIN exome
AF:
0.171
Gnomad NFE exome
AF:
0.220
Gnomad OTH exome
AF:
0.203
GnomAD4 exome
AF:
0.214
AC:
310203
AN:
1451880
Hom.:
35352
Cov.:
29
AF XY:
0.211
AC XY:
152200
AN XY:
722954
show subpopulations
African (AFR)
AF:
0.103
AC:
3446
AN:
33334
American (AMR)
AF:
0.293
AC:
13076
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
4520
AN:
26058
East Asian (EAS)
AF:
0.0748
AC:
2964
AN:
39612
South Asian (SAS)
AF:
0.120
AC:
10292
AN:
86008
European-Finnish (FIN)
AF:
0.175
AC:
9319
AN:
53386
Middle Eastern (MID)
AF:
0.120
AC:
691
AN:
5748
European-Non Finnish (NFE)
AF:
0.230
AC:
254138
AN:
1102966
Other (OTH)
AF:
0.196
AC:
11757
AN:
60086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
10149
20298
30447
40596
50745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8520
17040
25560
34080
42600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.184
AC:
27972
AN:
152138
Hom.:
2847
Cov.:
32
AF XY:
0.182
AC XY:
13499
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.115
AC:
4783
AN:
41516
American (AMR)
AF:
0.271
AC:
4134
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
541
AN:
3466
East Asian (EAS)
AF:
0.0688
AC:
357
AN:
5188
South Asian (SAS)
AF:
0.125
AC:
603
AN:
4824
European-Finnish (FIN)
AF:
0.165
AC:
1743
AN:
10582
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.224
AC:
15232
AN:
67978
Other (OTH)
AF:
0.187
AC:
396
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1130
2261
3391
4522
5652
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.210
Hom.:
5495
Bravo
AF:
0.187
Asia WGS
AF:
0.126
AC:
438
AN:
3478
EpiCase
AF:
0.217
EpiControl
AF:
0.219

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jun 13, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Benign based on MAF (12-22% in ESP populations) -

Feb 09, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 44% of patients studied by a panel of primary immunodeficiencies. Number of patients: 42. Only high quality variants are reported. -

not provided Benign:2Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hermansky-Pudlak syndrome 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
13
DANN
Benign
0.86
PhyloP100
3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=48/52
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0014
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4532349; hg19: chr5-77473165; COSMIC: COSV54880120; API